My ePortfolio Register   

Personalised therapy for lung cancer

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Submit
Thanks for rating
There has been a problem, please refresh and try again.
Published: 21.12.16
Views: 344

Dr Andre Marcio Murad - Clinica Cenantron, Belo Horizonte, Brazil

Dr Murad speaks with ecancertv at the IX French-Brazilian Oncology Congress about driver mutations that can guide selection of therapies for treating lung cancer.

He describes diagnostic assays which can identify actionable mutations, and the value of next generation sequencing in reporting a more complete genomic analysis of samples.

Related videos

follow us



Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

Cancer Intelligence